Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.60 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.58 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15317666 | 0.88 | ALDH1A1 (0.69) | MEN1KMT2AALDH1A1SMN1; SMN2HTT | |
| SCHEMBL3712268 | 0.86 | MEN1 (0.67) | MEN1KMT2AALDH1A1GRM3MAPT | |
| SCHEMBL16823768 | 0.86 | MEN1 (0.65) | MEN1KMT2AALDH1A1SMN1; SMN2HTT | |
| SCHEMBL15317656 | 0.83 | MEN1 (0.66) | MEN1KMT2AALDH1A1SMN1; SMN2HTT | |
| SCHEMBL15317685 | 0.83 | MEN1 (0.66) | MEN1KMT2AALDH1A1SMN1; SMN2HTT | |
| SCHEMBL15317689 | 0.83 | MEN1 (0.66) | MEN1KMT2AALDH1A1SMN1; SMN2HTT | |
| SCHEMBL6504711 | 0.83 | MEN1 (0.75) | MEN1KMT2AALDH1A1SMN1; SMN2HTT | |
| SCHEMBL15317678 | 0.83 | MAPT (0.69) | MEN1KMT2AALDH1A1SMN1; SMN2HTT | |
| SCHEMBL6270590 | 0.83 | HPGD (0.73) | MEN1KMT2AALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL1520334 | 0.83 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2GRM3HPGDGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166088-A1 | BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS | RANBAXY LABORATORIES LIMITED (IN) | 2011-07-07 | — | — | US | disclosed |
| US-20110166088-A1 | BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS | RANBAXY LABORATORIES LIMITED (IN) | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166088-A1 | BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS | TOP2B, TOP1, POLI | MEN1 4372/4885KMT2A 231/4885ALDH1A1 2009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.